首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia.
【24h】

Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia.

机译:初始抗生素选择和延迟适当治疗对金黄色葡萄球菌菌血症的影响。

获取原文
获取原文并翻译 | 示例
       

摘要

The study presented here investigated the impact of initial antibiotic choice (beta-lactams vs vancomycin) on the outcome of 342 patients with Staphylococcus aureus bacteremia (50.9% with methicillin-resistant isolates) encountered between 1 January 2002 and 30 June 2003. Initial antibiotics were inappropriate (beta-lactams) in 60 (34.5%) methicillin-resistant cases and suboptimal (vancomycin) in 62 (36.9%) methicillin-susceptible cases. Time to effective antibiotic therapy was longer in methicillin-resistant cases (25.5+/-28.6 vs 9.6+/-16.6 h; p<0.0005). All-cause in-hospital mortality was higher with inappropriate therapy (35.0 vs 20.9%; p=0.02). Initial vancomycin treatment was associated with a higher incidence of delayed clearance (>or=3 days) of methicillin-susceptible bacteremia (56.3 vs 37.0%; p=0.03). The results indicate inappropriate initial therapy is associated with higher in-hospital mortality and initial vancomycin may delay clearance.
机译:此处进行的研究调查了最初的抗生素选择(β-内酰胺与万古霉素)对2002年1月1日至2003年6月30日之间发生的342例金黄色葡萄球菌菌血症(对耐甲氧西林的菌株为50.9%)的结果的影响。 60例(34.5%)耐甲氧西林的患者使用了不适当的(β-内酰胺类药物),62例(36.9%)的甲氧西林易感患者使用了次优(万古霉素)药物。在耐甲氧西林的病例中,有效的抗生素治疗时间更长(25.5 +/- 28.6 vs 9.6 +/- 16.6 h; p <0.0005)。不适当的治疗导致全因住院死亡率更高(35.0 vs 20.9%; p = 0.02)。最初的万古霉素治疗与甲氧西林敏感菌血症的延迟清除(>或= 3天)发生率更高(56.3 vs 37.0%; p = 0.03)。结果表明不适当的初始治疗与较高的院内死亡率相关,初始万古霉素可能会延迟清除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号